XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Jun. 30, 2023
Current assets    
Cash and cash equivalents $ 219 $ 367
Receivables, net 673 688
Inventories, net 674 696
Prepaid expenses and other current assets 95 77
Total current assets 1,661 1,828
Property, plant and equipment, net of accumulated depreciation and amortization of $2,800 and $2,705, respectively 1,292 1,345
Operating lease right-of-use assets 379 346
Goodwill 1,229 1,252
Trademarks, net 539 543
Other intangible assets, net 149 169
Other assets 556 462
Total assets 5,805 5,945 Close
Current liabilities    
Notes and loans payable 111 50
Current operating lease liabilities 82 87
Accounts payable and accrued liabilities 1,653 1,659
Income taxes payable 0 121
Total current liabilities 1,846 1,917
Long-term debt 2,480 2,477
Long-term operating lease liabilities 347 310
Other liabilities 853 825
Deferred income taxes 24 28
Total liabilities 5,550 5,557 Close
Commitments and contingencies
Stockholders’ equity    
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2024 and June 30, 2023; and 124,186,844 and 123,820,022 shares outstanding as of March 31, 2024 and June 30, 2023, respectively 131 131
Additional paid-in capital 1,270 1,245
Retained earnings 34 583
Treasury stock, at cost: 6,554,617 and 6,921,439 shares as of March 31, 2024 and June 30, 2023, respectively (1,189) (1,246)
Accumulated other comprehensive net (loss) income (155) (493)
Total Clorox stockholders’ equity 91 220
Noncontrolling interests 164 168
Total stockholders’ equity 255 388 Close
Total liabilities and stockholders’ equity $ 5,805 $ 5,945